Back to team overview
Dr. Stefanie Parchmann
Partner
German Patent Attorney
European Patent Attorney
Chemist
Stefanie advises and represents clients from the pharmaceutical, biotechnology, biochemical and chemical industries through all stages of patent prosecution and as well as in patent opposition and appeal proceedings. She also prepares freedom-to-operate and validity opinions.
Having worked for many years as laboratory supervisor and project coordinator in custom manufacturing with a large chemical-pharmaceutical company, Stefanie has first-hand knowledge of the needs of industry with regard to intellectual property protection.
Stefanie lectures on patent law at the Technical University of Munich. As of 01.01.2020 Stefanie has been appointed as member of one of the Examination Committees for the European Qualifying Examination for professional representatives (European patent attorneys).
Within our firm, Stefanie is responsible for the central coordination of the training of the patent attorney candidates.
"I have worked with Maiwald in Munich. They had very good people, like Stefanie Parchmann."
– CLIENT | CHAMBERS EUROPE 2024
- Patent prosecution and portfolio management
- Filing strategies and drafting patent applications
- Freedom-to-operate and validity analysis
- Opposition and nullity proceedings
- Patent litigation
- Recommended in Legal 500 Deutschland 2023
- New referral to the EBoA: post-filed experimental evidence and plausibility, 2021
- Enlarged Board of Appeal Rules on Double Patenting, 2021
- Determining litigation value in patent appeals, 2018
- Chocolate bunnies cannot be trade marks, 2011
-
Chocolate trademarks reviewed, Managing Intellectual Property, 2010
-
Binding effect of EPO decisions, Managing Intellectual Property, 2010
-
EPO Enlarged Board to consider dosage regimen claims, Managing Intellectual Property, 2008
-
London Agreement and Enforcement Directive implemented, Managing Intellectual Property, 2008
- Representation of a client before the Enlarged Board of Appeal of the European Patent Office in proceedings G1/16, which led to a hallmark decision on the use of disclaimers in patent claims
- Representation of a generics company in infringement proceedings and opposition proceedings regarding a calcium receptor-active compound (see i.a. Munich Higher Regional Court: 6 U 6968/20)
- German Patent Attorney Association
- epi
- FICPI
- GRUR
- German
- English
